The board of directors of China NT Pharma Group Company Limited announced that Mr. Wu Weizhong has tendered his resignation as an executive Director of the Company and senior vice president of the Group with effect from 24 August 2022 for the reason that he wishes to spend more time on the main operation of the Group's wholly-owned subsidiary. Mr. Wu remains as an executive director and his positions of Suzhou First Pharmaceutical Co., Ltd, a limited liability company established in the PRC and a wholly-owned subsidiary of the Company. Mr. Wu has confirmed that there is no disagreement with the Board and there is no matter relating to his resignation that need to be brought to the attention of the shareholders of the Company or The Stock Exchange of Hong Kong Limited.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.026 HKD | +8.33% | -7.14% | -52.73% |
03-28 | China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-15 | China NT Pharma Group Company Limited Announces Directorate Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-52.73% | 8.11M | |
+18.67% | 43.74B | |
+21.99% | 22.26B | |
+16.41% | 14.9B | |
+9.03% | 13.39B | |
+40.48% | 12.12B | |
-9.64% | 6.92B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.47B |
- Stock Market
- Equities
- 1011 Stock
- News China NT Pharma Group Company Limited
- China NT Pharma Group Company Limited Announces Resignation of Wu Weizhong as Executive Director and Senior Vice President